Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.910
+0.050 (1.03%)
At close: Dec 3, 2025, 4:00 PM EST
5.10
+0.19 (3.87%)
Pre-market: Dec 4, 2025, 5:11 AM EST
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $3.04 million as of December 4, 2025. Its market cap has increased by 44.67% in one year.
Market Cap
3.04M
Enterprise Value
-1.80M
1-Year Change
44.67%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since October 28, 2016, Biodexa Pharmaceuticals's market cap has decreased from $55.80M to $3.04M, a decrease of -94.55%. That is a compound annual growth rate of -27.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 3.04M | 29.31% |
| Dec 31, 2024 | 2.35M | -66.49% |
| Dec 29, 2023 | 7.02M | 64.98% |
| Dec 30, 2022 | 4.26M | -67.32% |
| Dec 31, 2021 | 13.02M | -43.85% |
| Dec 31, 2020 | 23.19M | 52.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 947.22B |
| Johnson & Johnson | 494.72B |
| AbbVie | 397.86B |
| UnitedHealth Group | 292.78B |
| AstraZeneca | 283.73B |
| Merck & Co. | 252.74B |
| Novartis AG | 249.18B |
| Abbott Laboratories | 222.59B |